NoviPlex™ BLOOD COLLECTION DEVICES

Noviplex™ Remote Plasma Collection Device 

 

  • The Noviplex™ remote plasma collection device is for scientists, pharmaceutical companies, and government agencies who need to collect plasma samples in very remote areas.   

  • Unlike common blood spot cards and venous blood draw, the Noviplex collects a very accurate plasma sample that will survive long term storage in temperature ranges from -5°F to 110°F (-23°C to 43°C). ​

  • The Noviplex uses advanced membrane systems to pull the plasma from whole blood while leaving the blood cells behind. Rapid air drying stabilizes the sample in minutes for storage or shipping.​

  • Cooling and a source of power are NOT needed to prepare the blood sample for shipping.

  • Noviplex cards do not show hematocrit effects and only have to be analyzed once, since the entire plasma sample is used for analysis. In addition, Noviplex cards are more stable and generate analytical results that better agree with plasma analysis by conventional methods.

  • Novilytic was selected for an R&D 100 Award for the Noviplex™ Plasma Card. Noviplex cards were the first commercial product to produce plasma from a few drops of blood without the use of centrifugation or any power source. The Noviplex Duo Plasma Card was the first commercial device to split a single application of blood into two equivalent plasma samples without the use of a pipette or mechanical splitter.

Noviplex UNO – Plasma Prep Card

 

Typical Applications

  • Remote blood collection

  • Metabolomics studies

  • Protein biomarkers

  • Drug testing

Noviplex DUO – Plasma Prep Card

 

Typical Applications

  • DMPK assays where an archive sample is needed

  • Tests that require more sensitivity

  • Drug testing where an archive sample is required

TESTIMONIAL

Architectural Structure

"Duchenne muscular dystrophy (DMD) is a rare and fatal genetic disorder that primarily affects boys and results in deterioration of their skeletal, heart and lung muscles. Most children are diagnosed between ages 3-5, lose their ability to walk in their early teens and start having serious heart and lung complications in their late teens or early twenties.

 

Our clinical trial is the first to receive funding from the FDA Orphan Product division. Since DMD boys’ veins are challenging to phlebotomize and given the painful hardship multiple PK blood draws poses, we collaborated with a team of experts to rapidly develop and validate a novel method using the Noviplex dry plasma card which requires only two drops of whole blood from a finger stick!

 

This innovative tool will provide exceptional precision and stability for measuring the PK of our drug product and its metabolite thereby circumventing the pain and inconvenience of multiple venipunctures for DMD boys. We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”

Ines Macias-Perez, Ph.D

Principle Scientist, Product Development

Cumberland Pharmaceuticals

CONTACT US

Phone: 800.588.9799 or 574.834.4080

Fax: 574.834.7427

Email: info@novilytic.com

Address: Novilytic, L.L.C.

1281 Win Hentschel Blvd.

Suite 2541

West Lafayette, IN 47906